Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Three studies confirm efficacy and safety of Chinese AD treatment agent

Aug. 14, 1998

French team discloses newly discovered 5-HT1A agonists

Aug. 14, 1998

Phase III trial of Ampligen for the treatment of CFS now underway

Aug. 14, 1998

New antimigraine drug candidate discussed by Pierre Fabre at IUPHAR meeting

Aug. 13, 1998

Antidepressant efficacy established with new addition to the Ampakine family

Aug. 13, 1998

Joint research project will evaluate ABS-103 for the treatment of epilepsy

Aug. 13, 1998

Sepracor patents single-isomer form of zopiclone for treatment of sleep disorders

Aug. 13, 1998

French team discovers ciproxifan, a histaminergic agent with clinical potential in AD

Aug. 12, 1998

ADIR discovers new compounds with affinity for imidazoline receptors

Aug. 12, 1998

Searle withdraws support for development of CCD-3693; CoCensys will forge ahead

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...